tradingkey.logo

QuidelOrtho Corp

QDEL
29.100USD
+0.410+1.43%
종가 02/06, 16:00ET시세는 15분 지연됩니다
1.98B시가총액
손실P/E TTM

QuidelOrtho Corp

29.100
+0.410+1.43%

자세한 내용은 QuidelOrtho Corp 회사

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.

QuidelOrtho Corp 정보

종목 코드 QDEL
회사 이름QuidelOrtho Corp
상장일Feb 01, 1991
CEOBlaser (Brian J)
직원 수6600
유형Ordinary Share
회계 연도 종료Feb 01
주소9975 Summers Ridge Road
도시SAN DIEGO
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호92121
전화18585521100
웹사이트https://www.quidelortho.com/
종목 코드 QDEL
상장일Feb 01, 1991
CEOBlaser (Brian J)

QuidelOrtho Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
104.41K
+9215.00%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
72.55K
+4929.00%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
39.40K
+5823.00%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
38.99K
+6959.00%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
25.14K
+13691.00%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
21.35K
+5650.00%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
15.02K
+750.00%
Mr. John R. Chiminski
Mr. John R. Chiminski
Independent Director
Independent Director
2.52K
+2523.00%
Dr. Mary Lake Polan, M.D., Ph.D.
Dr. Mary Lake Polan, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Kenneth Jon (Ken) Widder, M.D.
Dr. Kenneth Jon (Ken) Widder, M.D.
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
104.41K
+9215.00%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
72.55K
+4929.00%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
39.40K
+5823.00%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
38.99K
+6959.00%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
25.14K
+13691.00%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
21.35K
+5650.00%

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Labs
373.80M
53.41%
Point-of-Care
164.60M
23.52%
Immunohematology
142.00M
20.29%
Donor Screening
14.70M
2.10%
Molecular Diagnostic Solutions
4.80M
0.69%
지역별USD
이름
수익
비율
North America
381.40M
54.49%
Other
142.10M
20.30%
EMEA
91.80M
13.12%
China
84.60M
12.09%
사업별
지역별
사업별USD
이름
수익
비율
Labs
373.80M
53.41%
Point-of-Care
164.60M
23.52%
Immunohematology
142.00M
20.29%
Donor Screening
14.70M
2.10%
Molecular Diagnostic Solutions
4.80M
0.69%

주식 보유 통계

마지막 업데이트: Mon, Nov 17
마지막 업데이트: Mon, Nov 17
주주
주주 유형
주주
주주
비율
T. Rowe Price Investment Management, Inc.
16.21%
BlackRock Institutional Trust Company, N.A.
13.72%
The Vanguard Group, Inc.
11.09%
Rubric Capital Management LP
6.83%
Fidelity Management & Research Company LLC
6.54%
기타
45.61%
주주
주주
비율
T. Rowe Price Investment Management, Inc.
16.21%
BlackRock Institutional Trust Company, N.A.
13.72%
The Vanguard Group, Inc.
11.09%
Rubric Capital Management LP
6.83%
Fidelity Management & Research Company LLC
6.54%
기타
45.61%
주주 유형
주주
비율
Investment Advisor
68.40%
Investment Advisor/Hedge Fund
35.50%
Hedge Fund
14.78%
Research Firm
2.25%
Pension Fund
1.00%
Individual Investor
1.00%
Private Equity
0.71%
Bank and Trust
0.55%
Sovereign Wealth Fund
0.52%

기관 주식 보유

마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
657
83.91M
123.52%
-20.38M
2025Q3
656
79.44M
116.95%
-23.17M
2025Q2
684
78.51M
115.63%
-21.42M
2025Q1
726
76.59M
113.26%
-21.60M
2024Q4
747
75.07M
111.30%
-13.02M
2024Q3
744
73.58M
109.44%
-4.02M
2024Q2
767
70.18M
104.79%
-7.57M
2024Q1
799
67.05M
100.24%
-5.28M
2023Q4
828
68.21M
102.09%
-2.95M
2023Q3
842
70.19M
105.17%
-4.01M
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
T. Rowe Price Investment Management, Inc.
11.01M
16.21%
-124.03K
-1.11%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
9.32M
13.72%
+39.16K
+0.42%
Sep 30, 2025
The Vanguard Group, Inc.
7.60M
11.19%
-165.71K
-2.13%
Sep 30, 2025
Rubric Capital Management LP
4.64M
6.83%
--
--
Sep 30, 2025
Fidelity Management & Research Company LLC
4.44M
6.54%
+1.89M
+73.81%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
2.86M
4.21%
+350.64K
+13.98%
Sep 30, 2025
Newtyn Management, LLC
2.70M
3.97%
+994.33K
+58.30%
Sep 30, 2025
State Street Investment Management (US)
2.67M
3.93%
-32.20K
-1.19%
Sep 30, 2025
Invesco Advisers, Inc.
2.66M
3.92%
+1.33M
+100.02%
Sep 30, 2025
American Century Investment Management, Inc.
2.12M
3.11%
+199.91K
+10.44%
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Tue, Dec 2
마지막 업데이트: Tue, Dec 2
이름
비율
State Street SPDR S&P Health Care Equipment ETF
1.75%
Invesco S&P SmallCap Health Care ETF
1.12%
Ballast Small/Mid Cap ETF
0.94%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.56%
JPMorgan Fundamental Data Science Small Core ETF
0.35%
State Street SPDR S&P 600 Small Cap Value ETF
0.26%
Avantis US Small Cap Value ETF
0.26%
iShares S&P Small-Cap 600 Value ETF
0.25%
iShares U.S. Medical Devices ETF
0.22%
State Street SPDR S&P SmallCap 600 ESG ETF
0.19%
더 보기
State Street SPDR S&P Health Care Equipment ETF
비율1.75%
Invesco S&P SmallCap Health Care ETF
비율1.12%
Ballast Small/Mid Cap ETF
비율0.94%
First Trust Nasdaq Lux Digi Health Solutions ETF
비율0.56%
JPMorgan Fundamental Data Science Small Core ETF
비율0.35%
State Street SPDR S&P 600 Small Cap Value ETF
비율0.26%
Avantis US Small Cap Value ETF
비율0.26%
iShares S&P Small-Cap 600 Value ETF
비율0.25%
iShares U.S. Medical Devices ETF
비율0.22%
State Street SPDR S&P SmallCap 600 ESG ETF
비율0.19%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI